BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

710 related articles for article (PubMed ID: 20093985)

  • 1. Serum glial fibrillary acidic protein is a highly specific biomarker for traumatic brain injury in humans compared with S-100B and neuron-specific enolase.
    Honda M; Tsuruta R; Kaneko T; Kasaoka S; Yagi T; Todani M; Fujita M; Izumi T; Maekawa T
    J Trauma; 2010 Jul; 69(1):104-9. PubMed ID: 20093985
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Serum S-100B protein and neuron-specific enolase after traumatic brain injury].
    Sawauchi S; Taya K; Murakami S; Ishi T; Ohtsuka T; Kato N; Kaku S; Tanaka T; Morooka S; Yuhki K; Urashima M; Abe T
    No Shinkei Geka; 2005 Nov; 33(11):1073-80. PubMed ID: 16277220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum neuron-specific enolase, S100B, and myelin basic protein concentrations after inflicted and noninflicted traumatic brain injury in children.
    Berger RP; Adelson PD; Pierce MC; Dulani T; Cassidy LD; Kochanek PM
    J Neurosurg; 2005 Jul; 103(1 Suppl):61-8. PubMed ID: 16122007
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuron-specific enolase, S100B, and glial fibrillary acidic protein levels as outcome predictors in patients with severe traumatic brain injury.
    Böhmer AE; Oses JP; Schmidt AP; Perón CS; Krebs CL; Oppitz PP; D'Avila TT; Souza DO; Portela LV; Stefani MA
    Neurosurgery; 2011 Jun; 68(6):1624-30; discussion 1630-1. PubMed ID: 21368691
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic value of S100B and neuron-specific enolase in mild pediatric traumatic brain injury.
    Geyer C; Ulrich A; Gräfe G; Stach B; Till H
    J Neurosurg Pediatr; 2009 Oct; 4(4):339-44. PubMed ID: 19795965
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurological injury markers in children with septic shock.
    Hsu AA; Fenton K; Weinstein S; Carpenter J; Dalton H; Bell MJ
    Pediatr Crit Care Med; 2008 May; 9(3):245-51. PubMed ID: 18446104
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased serum-GFAP in patients with severe traumatic brain injury is related to outcome.
    Nylén K; Ost M; Csajbok LZ; Nilsson I; Blennow K; Nellgård B; Rosengren L
    J Neurol Sci; 2006 Jan; 240(1-2):85-91. PubMed ID: 16266720
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum S-100B is superior to neuron-specific enolase as an early prognostic biomarker for neurological outcome following cardiopulmonary resuscitation.
    Shinozaki K; Oda S; Sadahiro T; Nakamura M; Abe R; Nakada TA; Nomura F; Nakanishi K; Kitamura N; Hirasawa H
    Resuscitation; 2009 Aug; 80(8):870-5. PubMed ID: 19535196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of serum biomarkers to predict cerebral hypoxia after severe traumatic brain injury.
    Stein DM; Lindell AL; Murdock KR; Kufera JA; Menaker J; Bochicchio GV; Aarabi B; Scalea TM
    J Neurotrauma; 2012 Apr; 29(6):1140-9. PubMed ID: 22360297
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GFAP and S100B are biomarkers of traumatic brain injury: an observational cohort study.
    Vos PE; Jacobs B; Andriessen TM; Lamers KJ; Borm GF; Beems T; Edwards M; Rosmalen CF; Vissers JL
    Neurology; 2010 Nov; 75(20):1786-93. PubMed ID: 21079180
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum- and CSF-concentrations of brain specific proteins in hydrocephalus.
    Beems T; Simons KS; Van Geel WJ; De Reus HP; Vos PE; Verbeek MM
    Acta Neurochir (Wien); 2003 Jan; 145(1):37-43. PubMed ID: 12545260
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated serum levels of S-100beta protein and neuron-specific enolase are associated with brain injury in patients with severe sepsis and septic shock.
    Nguyen DN; Spapen H; Su F; Schiettecatte J; Shi L; Hachimi-Idrissi S; Huyghens L
    Crit Care Med; 2006 Jul; 34(7):1967-74. PubMed ID: 16607230
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Update on protein biomarkers in traumatic brain injury with emphasis on clinical use in adults and pediatrics.
    Kövesdi E; Lückl J; Bukovics P; Farkas O; Pál J; Czeiter E; Szellár D; Dóczi T; Komoly S; Büki A
    Acta Neurochir (Wien); 2010 Jan; 152(1):1-17. PubMed ID: 19652904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Electroconvulsive therapy and biomarkers of neuronal injury and plasticity: Serum levels of neuron-specific enolase and S-100b protein.
    Palmio J; Huuhka M; Laine S; Huhtala H; Peltola J; Leinonen E; Suhonen J; Keränen T
    Psychiatry Res; 2010 May; 177(1-2):97-100. PubMed ID: 20378182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuron-specific enolase and S-100B are associated with neurologic outcome after pediatric cardiac arrest.
    Topjian AA; Lin R; Morris MC; Ichord R; Drott H; Bayer CR; Helfaer MA; Nadkarni V
    Pediatr Crit Care Med; 2009 Jul; 10(4):479-90. PubMed ID: 19307814
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GFAP and S100B in the acute phase of mild traumatic brain injury.
    Metting Z; Wilczak N; Rodiger LA; Schaaf JM; van der Naalt J
    Neurology; 2012 May; 78(18):1428-33. PubMed ID: 22517109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictive value of S-100B protein and neuron specific-enolase as markers of traumatic brain damage in clinical use.
    Naeimi ZS; Weinhofer A; Sarahrudi K; Heinz T; Vécsei V
    Brain Inj; 2006 May; 20(5):463-8. PubMed ID: 16716992
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The prognostic value of neuron-specific enolase in head trauma patients.
    Meric E; Gunduz A; Turedi S; Cakir E; Yandi M
    J Emerg Med; 2010 Apr; 38(3):297-301. PubMed ID: 18499387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glial and neuronal proteins in serum predict outcome after severe traumatic brain injury.
    Vos PE; Lamers KJ; Hendriks JC; van Haaren M; Beems T; Zimmerman C; van Geel W; de Reus H; Biert J; Verbeek MM
    Neurology; 2004 Apr; 62(8):1303-10. PubMed ID: 15111666
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum levels of glial fibrillary acidic protein correlate to tumour volume of high-grade gliomas.
    Brommeland T; Rosengren L; Fridlund S; Hennig R; Isaksen V
    Acta Neurol Scand; 2007 Dec; 116(6):380-4. PubMed ID: 17986096
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.